SlideShare a Scribd company logo
April 2020
Reference: Robbins & Cotran Pathology and Rubin’s Pathology
Sufia Husain
Associate Professor
Pathology Department
College of Medicine
KSU, Riyadh
Renal Pathology
Nephrotic Syndrome
&
Nephritic Syndrome
Objectives for pathology lectures 5 & 6:
Rapid Progressive Glomerulonephritis, Chronic kidney Disease,
AND
Nephrotic and Nephritic Syndrome:
At the end of the activity (2 lectures) the students will be able to:
 Recognize the five major renal glomerular syndromes.
 Describe the main differential pathological diagnosis for each syndrome.
 Perform a clinico-pathological correlation.
 Describe the patterns of injury of each syndrome.
Key Outlines:
 The nephrotic syndrome: (Minimal change, FSGS, membranous, diabetes).
 The nephritic syndrome: (Acute post streptococcal Glomerulonephritis GN, Lupus nephritis).
 Asymptomatic Hematuria: IgA Nephropathy.
 Rapidly progressive GN: (Crescentic GN)
 The Chronic Renal Failure.
Outline for lecture 5
 Introduction, kidney biopsy
 Location of electron dense immune deposits
 Pathogenesis of glomerular disease
 Common markers of renal diseases
 Clinical manifestation of kidney disease
 Nephrotic Syndrome
 Minimal change disease
 Focal segmental glomerulosclerosis
 Membranous GN
 Diabetes mellitus
 Nephritic Syndrome
 Acute post-streptococcal GN
 Introduction to lupus nephritis
 Hematuria
 IgA Nephropathy
https://www.niddk.nih.gov/research-funding/at-niddk/labs-
branches/kidney-diseases-branch/kidney-disease-
section/glomerular-disease-primer/normal-kidney
Glomerulus n Transmission EM
Kidney histology
Kidney biopsy
The tissue obtained is used to make slides for
1. Light microscopy (LM) to study renal histology.
2. Immunofluorescence (IF) study is to detect
 the presence of immunoglobulins (IgA, IgG, IgM) and complements (C3 and C1q) in the
glomeruli (in the mesangium or in the glomerular capillary loop wall.
3. Electron microscopy (EM) (ultrastructural) study is to detect the
presence or absence of
 effacement of the epithelial cell (podocytes)foot processes.
 electron dense immune complex deposits
 And if deposits are present then to identify the location of the deposits in the glomeruli
(mesangial/paramesangial, subepithelial, subendothelial).
Kidney biopsy
LOCATIONS OF ELECTRON DENSE
IMMUNE DEPOSITS
Deposits (depicted in black)Normal glomerular capillary loop
Common locations of electron dense immune deposits.
Note: the locations are different in different diseases.
Image from IM Bajema et al.: Revision of lupus nephritis classification. Kidney International · February 2018 DOI: 10.1016/j.kint.2017.11.023
PATHOGENESIS OF GLOMERULAR INJURY
Pathogenesis of glomerular injury
Glomerulonephritis (GN) is frequently caused by immunologic mechanisms both antibody-mediated
(mainly) and cell-mediated types of immunity play roles in the production of glomerular inflammation.
1. Antibody-mediated immune GN: there are 3 major mechanisms of antibody-mediated inflammation.
They are:
a) In situ immune complex formation: certain circulating antibodies react with certain antigens that
are already present in glomeruli  formation deposition of these immune complexes in the
glomeruli. These deposits attract leukocytes and activate complement glomerular injury.
Pathogenesis of glomerular injury contd..
b) Antigen-antibody reaction take place in circulation and these preformed circulating immune
complexes are deposited in the glomeruli  deposits trigger glomerular injury (by attracting
inflammatory cells and activate complements). (the antigen can be a bacteria, virus etc.)
Pathogenesis of glomerular injury contd..
c) Antineutrophil cytoplasmic autoantibodies (ANCAs): they cause a severe type of GN in which the
patients have circulating autoantibodies against antigens present in neutrophil cytoplasm. This
interaction leads to activation and adhesion of the neutrophils to endothelial cells lining the
capillaries especially the glomerular capillaries. The neutrophils release injurious products that
promote endothelial injury, vascular inflammation (vasculitis) and GN.
All 3 initiate of glomerular inflammatory injury by attraction and activation of leukocytes.
2. Cell mediated immune GN: sensitized T cells also cause glomerular injury.
https://unckidneycenter.org/files/2017/10/anca-vasculitis-vessel-wall.png
COMMON MARKERS OF RENAL DISEASES
In blood
 Serum creatinine and BUN
In urine analysis
 Proteinuria: presence of abnormal quantities of protein in the urine
 Hematuria: presence of rbcs in urine (smoky brown urine). It is a result of glomerular injury and rupture of
the glomerular capillaries with resultant bleeding into the Bowman’s/ urinary space.
 Casts: these rbcs mix with proteinaceous material in the tubules and forms rbc casts (which are found in
the urine).
Common markers of renal diseases
https://unckidneycenter.org/files
CLINICAL MANIFESTATION OF KIDNEY DISEASE
Clinical manifestation of kidney disease
 Nephritic syndrome Results from glomerular injury  acute onset of hematuria (rbcs in urine), mild to
moderate proteinuria, azotemia, edema & hypertension.
 Nephrotic syndrome heavy proteinuria (excretion of more than 3.5 g of protein/day in urine),
hypoalbuminemia, severe edema, hyperlipidemia, and lipiduria.
 Asymptomatic hematuria &/or
non-nephrotic proteinuria
a sign of mild glomerular abnormalities e.g. IgA nephropathy.
 Rapidly progressive
glomerulonephritis
Results from severe glomerular injury  loss of renal function within days or weeks
 hematuria, dysmorphic rbcs, rbc casts in urine, mild to moderate proteinuria.
 Acute kidney injury oliguria or anuria with recent onset of azotemia; can result from glomerular injury
(e.g. crescentic glomerulonephritis), interstitial injury, vascular injury (e.g. TMA) or
acute tubular injury/necrosis.
 Chronic kidney disease any chronic renal diseases that progresses to end stage kidney requiring dialysis and
transplantation.
 Urinary tract infection affect the kidney (pyelonephritis) or the bladder (cystitis)  bacteriuria and pyuria
(bacteria and leukocytes in urine).
 Nephrolithiasis (renal stones) renal colic, hematuria (without rbc casts).
 DIFFUSE: majority of the glomeruli are involved
 FOCAL: some of the glomeruli are involved
 SEGMENTAL: only part of a glomerular tuft is involved
 GLOBAL: involving the total glomerular tuft
Terminology
NEPHROTIC SYNDROME
Nephrotic syndrome is a group of clinical features that include the
following:
1. Massive proteinuria: is the loss in the urine of >3.5 g of
protein/day. This is due abnormal permeability of the glomerular
capillary wall.
2. Hypoproteinemia or hypoalbuminemia: plasma albumin levels
<3g/dL (this due to the loss of protein in the urine)
3. Odema: Hypoproteinemia causes reduced plasma colloid osmotic
pressure, salt and water retention and odema.
4. Hyperlipidemia and lipiduria: hypoalbuminemia causes
compensatory increase in lipoprotein secretion by the liver
leading to hyperlipidemia. At the same time there is increased
loss of lipid in the urine, lipiduria (due to abnormal permeability
of the GBM).
Note: in the beginning there is little or no azotemia, hematuria, or
hypertension (not part of definition of nephrotic syndrome).
Nephrotic syndrome
PRIMARY CAUSES
 Minimal change disease
 Membranous GN
 Focal segmental glomerulosclerosis (FSGS)
 Membranoproliferative GN (can also present as nephritic syndrome)
 Others
SECONDARY CAUSES
 Diabetes mellitus (most common systemic causes)
 Amyloidosis
 Systemic lupus erythematosus (it can also present as nephritic syndrome)
 Drugs (gold, penicillamine, "street heroin")
 Others
NOTE: In children the most common cause of nephrotic syndrome is minimal-change disease. In adults
the most common primary glomerular diseases that causes nephrotic syndrome are membranous
glomerulopathy in Caucasians and Asians, and FSGS is the most common etiology in American blacks.
Causes of nephrotic syndrome
Minimal change disease
Minimal change disease (MCD) is also known as
lipoid nephrosis.
It causes nephrotic syndrome.
Pathogenesis: unknown  usually idiopathic.
It is characterized by effacement of the foot
processes of the visceral epithelial cells (podocytes).
Light microscopy:
• Glomeruli  look normal.
• The proximal convoluted tubular cells are heavily
laden with protein droplets and lipids.
• There is no tubular atrophy or interstitial fibrosis.
Immunofluorescence microscopy:
• Is negative for immunoglobulins and complement.
Minimal change disease /glomerulopathy
MCD:
Electron microscopy:
• MCD is characterized by diffuse fusion
or effacement of the epithelial cell
(podocyte) foot processes.
• This effacement is due to the retraction
of the foot processes as a result of
extensive cell swelling.
NOTE: effacement occurs in virtually all
cases of nephrotic proteinuria; it is not
specific for minimal-change
glomerulopathy.
MCD: clinical features, treatment and prognosis
C/F include:
 Nephrotic syndrome
Treatment and prognosis:
 Over 90% of children and few adults have complete remission with corticosteroid therapy.
 Prognosis: good, especially in children.
 Some patients become steroid dependent i.e. they relapse each time corticosteroid treatment is stopped.
 Less than 5% develop chronic renal failure
FOCAL AND SEGMENTAL GLOMERULOSCLEROSIS
(FSGS)
FOCAL AND SEGMENTAL GLOMERULOSCLEROSIS
(FSGS)
LM:
 Occurs in older children and adults.
 Glomeruli at the corticomedullary junction are
commonly affected.
 Only some of the glomeruli are involved (i.e. focal).
 There is focal and segmental sclerosis of the
glomeruli (i.e. some glomeruli show sclerosis in a
segment of the glomerular tuft).
 Adhesions and hyalinosis +/-
IF: Usually negative. Sometimes IgM is positive.
EM: There is patchy/focal effacement of podocyte foot
processes.
Membranous glomerulopathy/ membranous
glomerulonephritis (GN)/ membranous nephropathy
 A frequent cause of the nephrotic syndrome in adults (commonly 30-50 years).
 The proteinuria does not usually respond to corticosteroid therapy
 Is an immune complex disease. The antigen-antibody immune complexes are formed either in-situ in the
glomeruli or are pre-formed in circulation and then deposited in the glomeruli.
 It is characterized by deposition of electron dense immune complexes in the subepithelial area in the
glomeruli (between the podocytes and the GBM).
 It is a slowly progressive disease. If not treated some cases  progress to fibrosis of the kidneys
(glomerular sclerosis, atrophy of tubules and interstitial fibrosis) and end stage disease/ renal failure.
 10% to 30% have a more benign course with good prognosis.
Membranous glomerulopathy/ nephropathy/ GN
Membranous glomerulopathy can be:
Primary/idiopathic membranous GN (80% of cases): in primary MN
there are autoantibodies against phospholipase A2 receptor 1
(PLA2R1) antigen.
Secondary membranous GN: causes include autoimmune disease
(SLE), infectious disease (hepatitis B virus infection), therapeutic
agents (penicillamine), neoplasms (lung cancer). Patient should be
investigated for secondary causes.
Membranous glomerulopathy/ nephropathy/ GN
Membranous glomerulopathy/ nephropathy/ GN
Light microscopy:
 The capillary walls of the glomeruli are diffusely thickened (due
to the subepithelial deposits seen on EM).
 The deposits are separated from each other by protrusions of
GBM matrix called spikes (bottom picture).
 As the disease progresses there is glomerular sclerosis and
interstitial fibrosis.
Membranous GN
IF: granular positivity for immunoglobulin IgG and complement C3 along the GBM.
EM: the immune complex appear in capillary walls as electron-dense deposits in the
subepithelial space. There is diffuse effacement of epithelial cell foot processes also.
DIABETIC NEPHROPATHY
DIABETIC NEPHROPATHY (DM)
Long standing poorly controlled DM  leads to kidney disease. Is a
common cause of secondary nephrotic syndrome.
LM: shows 2 types of lesions:
1. Diffuse glomerulosclerosis: all the glomeruli show increase in
mesangial matrix ending in sclerosis (top photo).
2. Nodular glomerulosclerosis (Kimmelstiel Wilson nodules): there
are nodules in the mesangium. These nodules are spherical and
eosinophilic, with a central acellular area. It is pathogonomic of
diabetic nephropathy (bottom photo).
Both show diffuse thickening of the glomerular basement membrane
If not treated can progress to  end staged kidney/ renal failure.
IF: negative.
EM: there is diffuse increase in the thickness of the glomerular
basement membrane.
NEPHRITIC SYNDROME
Nephritic syndrome is a clinical complex characterized by acute onset of:
 Hematuria (smoky brown urine). The hematuria is a result of glomerular injury and inflammatory
rupture of the glomerular capillaries with resultant bleeding into the Bowman’s space. The rbcs pass
into the tubules and mix with proteinaceous material in the tubules and forms rbc casts (which are
passed in the urine). The hemodynamic changes caused by the rupture lead to a reduction in the
glomerular filteration rate (GFR).
 Oliguria: is a result of the reduced GFR.
 Azotemia: increased blood urea nitrogen and creatinine. It is also a result of reduced GRF.
 Hypertension: it is a result of the fluid retention and renin release from the ischemic kidneys.
NOTE: There may be mild proteinuria and edema.
The example of nephritic syndrome include:
 Post-infectious glomerulonephritis: it is the most classical example.
 Lupus nephritis: can also present as nephrotic syndrome
Nephritic syndrome
Post-infectious glomerulonephritis (PIGN)
Post-infectious glomerulonephritis (PIGN)
It is a type of acute diffuse proliferative GN.
It is caused by deposition of immune complexes in glomeruli.
The most common cause of post-infectious glomerulonephritis is infection with
group A, beta-hemolytic streptococci and is therefore also called post-
streptococcal glomerulonephritis . Other infections include pneumococcal and
staphylococcal infections and viral diseases (mumps, measles, chickenpox etc.).
Usually there is a latent period between the exposure and the occurrence of
glomerulonephritis
Classically PIGN develops in children 1 to 4 weeks after streptococcal infection of
the pharynx (pharyngitis) or tonsils (tonsillitis) or the skin (impetigo or infected
insect bite).
This disease was more common in the past (because now we have antibiotics), but
it is still one of the common childhood renal diseases.
Post-infectious GN: pathogenesis
 The immune complexes are deposited in the glomeruli in the subepithelial area and are composed of IgG
and C3. The deposits initiate inflammation by
 activating complements: this way the complements get used up leading to development of
hypocomplementemia (serum C3 levels are low during the acute phase of disease).
 And activating various other inflammatory mediators
All these inflammatory mediators:
 attracts and activate neutrophils and monocytes
 stimulates proliferation of mesangial and endothelial cell proliferation.
These effects result in marked glomerular hypercellularity  resulting in diffuse proliferative
glomerulonephritis.
Post-infectious GN: Light microscopy
There is diffuse enlargement and hypercellularity of glomeruli due to proliferation of
endothelial cells and mesangial cells and infiltration of neutrophils and monocytes.
Crescents maybe present.
Glomerular necrosis maybe present.
All histologic changes resolve completely in most patients after several months
https://www.stepwards.com/wp-
content/uploads/2016/01/j6npaxvA2gcDQTLLEm7mdQ_m.png
IF: coarse granular (lumpy bumpy) IgG and C3 are positive along the capillary walls.
EM: characteristic subepithelial electron dense immune deposits. They look like dome
shaped humps (called subepithelial humps). The deposits clear up and disappear in a few
months.
Post-infectious GN
https://basicmedicalkey.com/wp-content/uploads/2016/12/image08134.jpeg
Post-infectious GN: clinical features
The onset of kidney disease is sudden.
Present as nephritic syndrome (oliguria, hematuria, hypertension and azotemia).
Serum C3 levels are low during the acute phase.
Diagnosis depends on serologic evidence of a rise in antibody titers to
streptococcal products e.g. ASO titre is positive.
This disease resolves in over 90% of patients. Rarely patients (usually adults)
develop progressive renal failure.
Grossly there is multiple punctate hemorrhagic spots on the kidney surface.
LUPUS NEPHROPATHY/ NEPHRITIS (LN)
LUPUS NEPHROPATHY/ NEPHRITIS (LN)
Patients with the autoimmune disease called systemic lupus erythematosus (SLE) tend
to have renal involvement and it is known as lupus nephritis (LN).
It can present as nephrotic or nephritic syndrome.
LN is an immune complex mediated disease in which there is the deposition of antigen
antibody complexes in the glomeruli. The deposits trigger an inflammatory response
which in turn triggers the proliferation of the epithelial, endothelial and mesangial
cells of the glomeruli. It can even lead to glomerular necrosis.
LN can be active or chronic or a combination of both.
The LN lesions have been classified into 6 classes by the International Society of
Nephrology/Renal Pathology Society (ISN/RPS). This classification helps give
information regarding the activity, chronicity and the prognosis of the disease.
HEMATURIA
 IgA nephropathy (IgAN) is one of the most common type of primary glomerulonephritis that
presents as hematuria
 IgAN is characterized by the deposition of IgA immunoglobulin in the mesangium/ paramesangium
of glomeruli.
 It usually present as hematuria only and sometimes as nephritic syndrome.
 When it occurs in combination with vasculitis (leukocytoclastic vasculitis) and multiorgan
involvement then is referred to as Henoch-Schonlein purpura.
Hematuria
IgA Nephropathy/Bergers disease
LM: is very variable (may or may not show  mesangial hypercellularity,
endocapillary hypercellularity, glomerular sclerosis, tubulo-interstitial scarring).
IF: dominant IgA stain positivity in the mesangium.
EM: immune complex deposits positive in the mesangium and paramesangial area.
https://webpath.med.utah.edu/jpeg2/RENAL096.jpg https://abdominalkey.com/wp-content/uploads/2016/06/C12-FF21-3.gif
END

More Related Content

What's hot

glomerular disease
glomerular diseaseglomerular disease
glomerular disease
Shruthi Mahesh
 
nephritic and nephrotic syndrome
   nephritic and nephrotic syndrome   nephritic and nephrotic syndrome
nephritic and nephrotic syndrome
jaynandanprasadsah2
 
Glomerulonephritis - Acute Nephritic Syndromes
Glomerulonephritis - Acute Nephritic SyndromesGlomerulonephritis - Acute Nephritic Syndromes
Glomerulonephritis - Acute Nephritic Syndromes
Chetan Ganteppanavar
 
The Kidney - GLOMERULAR DISEASES
The Kidney - GLOMERULAR DISEASESThe Kidney - GLOMERULAR DISEASES
The Kidney - GLOMERULAR DISEASES
Dr. Roopam Jain
 
MPGN
MPGNMPGN
Glomerulonephritis (1)
Glomerulonephritis (1)Glomerulonephritis (1)
Glomerulonephritis (1)
shashank agrawal
 
Acute Glomerulonephritis
Acute GlomerulonephritisAcute Glomerulonephritis
Acute Glomerulonephritis
Vishwanath Marshivanikar
 
Tubulointerstitial diseases of Kidney
Tubulointerstitial diseases of KidneyTubulointerstitial diseases of Kidney
Tubulointerstitial diseases of Kidney
Usman Shams
 
The KIDNEY - PATHOGENESIS OF GLOMERULAR DISEASES
The KIDNEY -  PATHOGENESIS OF GLOMERULAR DISEASESThe KIDNEY -  PATHOGENESIS OF GLOMERULAR DISEASES
The KIDNEY - PATHOGENESIS OF GLOMERULAR DISEASES
Dr. Roopam Jain
 
RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS(RPGN)
RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS(RPGN)RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS(RPGN)
RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS(RPGN)
Manjunath Anvekar
 
tubulointerstitial diseases-
 tubulointerstitial diseases- tubulointerstitial diseases-
tubulointerstitial diseases-
imrana tanvir
 
Glomerulonephritis
GlomerulonephritisGlomerulonephritis
Glomerulonephritis
mpatjawee
 
Ig A nephropathy
Ig A nephropathyIg A nephropathy
Ig A nephropathy
Dr Shami Bhagat
 
Glomerulonephritis
GlomerulonephritisGlomerulonephritis
Glomerulonephritis
Phûi Wakahora
 
pathology of renal syatem
pathology of renal syatempathology of renal syatem
pathology of renal syatem
Shruthi Mahesh
 
Lupus nephritis
Lupus nephritisLupus nephritis
Lupus nephritis
MR. JAGDISH SAMBAD
 
24 glomerular disease
24 glomerular disease24 glomerular disease
24 glomerular diseaseinternalmed
 
Renal tubulo interstitial diseases
Renal tubulo interstitial diseasesRenal tubulo interstitial diseases
Renal tubulo interstitial diseases
Medesun Healthcare Solutions LLC
 
Autoimmune Hemolytic Anemia (AIHA)
Autoimmune Hemolytic Anemia (AIHA)Autoimmune Hemolytic Anemia (AIHA)
Autoimmune Hemolytic Anemia (AIHA)
RGCL
 

What's hot (20)

glomerular disease
glomerular diseaseglomerular disease
glomerular disease
 
nephritic and nephrotic syndrome
   nephritic and nephrotic syndrome   nephritic and nephrotic syndrome
nephritic and nephrotic syndrome
 
Glomerulonephritis - Acute Nephritic Syndromes
Glomerulonephritis - Acute Nephritic SyndromesGlomerulonephritis - Acute Nephritic Syndromes
Glomerulonephritis - Acute Nephritic Syndromes
 
The Kidney - GLOMERULAR DISEASES
The Kidney - GLOMERULAR DISEASESThe Kidney - GLOMERULAR DISEASES
The Kidney - GLOMERULAR DISEASES
 
MPGN
MPGNMPGN
MPGN
 
Glomerulonephritis (1)
Glomerulonephritis (1)Glomerulonephritis (1)
Glomerulonephritis (1)
 
Acute Glomerulonephritis
Acute GlomerulonephritisAcute Glomerulonephritis
Acute Glomerulonephritis
 
Renal amyloidosis
Renal amyloidosisRenal amyloidosis
Renal amyloidosis
 
Tubulointerstitial diseases of Kidney
Tubulointerstitial diseases of KidneyTubulointerstitial diseases of Kidney
Tubulointerstitial diseases of Kidney
 
The KIDNEY - PATHOGENESIS OF GLOMERULAR DISEASES
The KIDNEY -  PATHOGENESIS OF GLOMERULAR DISEASESThe KIDNEY -  PATHOGENESIS OF GLOMERULAR DISEASES
The KIDNEY - PATHOGENESIS OF GLOMERULAR DISEASES
 
RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS(RPGN)
RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS(RPGN)RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS(RPGN)
RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS(RPGN)
 
tubulointerstitial diseases-
 tubulointerstitial diseases- tubulointerstitial diseases-
tubulointerstitial diseases-
 
Glomerulonephritis
GlomerulonephritisGlomerulonephritis
Glomerulonephritis
 
Ig A nephropathy
Ig A nephropathyIg A nephropathy
Ig A nephropathy
 
Glomerulonephritis
GlomerulonephritisGlomerulonephritis
Glomerulonephritis
 
pathology of renal syatem
pathology of renal syatempathology of renal syatem
pathology of renal syatem
 
Lupus nephritis
Lupus nephritisLupus nephritis
Lupus nephritis
 
24 glomerular disease
24 glomerular disease24 glomerular disease
24 glomerular disease
 
Renal tubulo interstitial diseases
Renal tubulo interstitial diseasesRenal tubulo interstitial diseases
Renal tubulo interstitial diseases
 
Autoimmune Hemolytic Anemia (AIHA)
Autoimmune Hemolytic Anemia (AIHA)Autoimmune Hemolytic Anemia (AIHA)
Autoimmune Hemolytic Anemia (AIHA)
 

Similar to Renal pathology lecture5 Nephrotic & Nephritic syndrome. Sufia Husain 2020

Chronic Kidney Disease.pptx
Chronic Kidney Disease.pptxChronic Kidney Disease.pptx
Chronic Kidney Disease.pptx
DrsantoshMaharjan
 
2 GLOMERULAR DISEASES.pptx
2 GLOMERULAR DISEASES.pptx2 GLOMERULAR DISEASES.pptx
2 GLOMERULAR DISEASES.pptx
ebisakedjela
 
Glomerulonephritis.pptx..................
Glomerulonephritis.pptx..................Glomerulonephritis.pptx..................
Glomerulonephritis.pptx..................
TARUNKUMAR472866
 
Secondary glomerular disorders.pptx
Secondary glomerular disorders.pptxSecondary glomerular disorders.pptx
Secondary glomerular disorders.pptx
farahalamleh
 
Glomerular disease postgraduate magdi sasi 2019
Glomerular disease postgraduate  magdi sasi 2019Glomerular disease postgraduate  magdi sasi 2019
Glomerular disease postgraduate magdi sasi 2019
cardilogy
 
Nephrotic syndrome [full]
Nephrotic syndrome [full]Nephrotic syndrome [full]
Nephrotic syndrome [full]
Mounir FOTSO BENNIS
 
Glomerulonephritis.pdf
Glomerulonephritis.pdfGlomerulonephritis.pdf
Glomerulonephritis.pdf
RATHODVIREN
 
glomerulonephritis (5).pptx
glomerulonephritis (5).pptxglomerulonephritis (5).pptx
glomerulonephritis (5).pptx
faisaliqbal142
 
Approach to the patient with Glomerular Disease.
Approach to the patient with Glomerular Disease.Approach to the patient with Glomerular Disease.
Approach to the patient with Glomerular Disease.
Sufindc
 
Nephrotic syndrome
Nephrotic syndromeNephrotic syndrome
Nephrotic syndrome
Lord Ceasar
 
NON PROLIFERATIVE GLOMERULONEPHRITIS
NON PROLIFERATIVE                    GLOMERULONEPHRITISNON PROLIFERATIVE                    GLOMERULONEPHRITIS
NON PROLIFERATIVE GLOMERULONEPHRITIS
VijayDhamgay1
 
Renal failure
Renal failureRenal failure
Renal failure
ariva zhagan
 
Nephrotic syndrome (Primary glomerulonephrosis)
Nephrotic syndrome (Primary glomerulonephrosis)Nephrotic syndrome (Primary glomerulonephrosis)
Nephrotic syndrome (Primary glomerulonephrosis)
kalyan kumar
 
1 glomerular disease &amp; anatomy pysiology of kideny
1 glomerular disease &amp; anatomy pysiology of kideny1 glomerular disease &amp; anatomy pysiology of kideny
1 glomerular disease &amp; anatomy pysiology of kideny
Engidaw Ambelu
 
Patho Kidney Presentation.pptx
Patho Kidney Presentation.pptxPatho Kidney Presentation.pptx
Patho Kidney Presentation.pptx
IsratAkhi
 
Nephrotic syndrome final
Nephrotic syndrome finalNephrotic syndrome final
Nephrotic syndrome finalakilav99
 
Glomerular Disease sem.pptx
Glomerular Disease sem.pptxGlomerular Disease sem.pptx
Glomerular Disease sem.pptx
Hussen39
 
ihdsflkjashdf;hadfhadkfhasp
ihdsflkjashdf;hadfhadkfhasp ihdsflkjashdf;hadfhadkfhasp
ihdsflkjashdf;hadfhadkfhasp me0328
 
Nephritis2008.
Nephritis2008.Nephritis2008.
Nephritis2008.Deep Deep
 
Renal pathology lecture 6 Rapid Progressive Glomerulonephritis & Chronic Kidn...
Renal pathology lecture 6 Rapid Progressive Glomerulonephritis & Chronic Kidn...Renal pathology lecture 6 Rapid Progressive Glomerulonephritis & Chronic Kidn...
Renal pathology lecture 6 Rapid Progressive Glomerulonephritis & Chronic Kidn...
Sufia Husain
 

Similar to Renal pathology lecture5 Nephrotic & Nephritic syndrome. Sufia Husain 2020 (20)

Chronic Kidney Disease.pptx
Chronic Kidney Disease.pptxChronic Kidney Disease.pptx
Chronic Kidney Disease.pptx
 
2 GLOMERULAR DISEASES.pptx
2 GLOMERULAR DISEASES.pptx2 GLOMERULAR DISEASES.pptx
2 GLOMERULAR DISEASES.pptx
 
Glomerulonephritis.pptx..................
Glomerulonephritis.pptx..................Glomerulonephritis.pptx..................
Glomerulonephritis.pptx..................
 
Secondary glomerular disorders.pptx
Secondary glomerular disorders.pptxSecondary glomerular disorders.pptx
Secondary glomerular disorders.pptx
 
Glomerular disease postgraduate magdi sasi 2019
Glomerular disease postgraduate  magdi sasi 2019Glomerular disease postgraduate  magdi sasi 2019
Glomerular disease postgraduate magdi sasi 2019
 
Nephrotic syndrome [full]
Nephrotic syndrome [full]Nephrotic syndrome [full]
Nephrotic syndrome [full]
 
Glomerulonephritis.pdf
Glomerulonephritis.pdfGlomerulonephritis.pdf
Glomerulonephritis.pdf
 
glomerulonephritis (5).pptx
glomerulonephritis (5).pptxglomerulonephritis (5).pptx
glomerulonephritis (5).pptx
 
Approach to the patient with Glomerular Disease.
Approach to the patient with Glomerular Disease.Approach to the patient with Glomerular Disease.
Approach to the patient with Glomerular Disease.
 
Nephrotic syndrome
Nephrotic syndromeNephrotic syndrome
Nephrotic syndrome
 
NON PROLIFERATIVE GLOMERULONEPHRITIS
NON PROLIFERATIVE                    GLOMERULONEPHRITISNON PROLIFERATIVE                    GLOMERULONEPHRITIS
NON PROLIFERATIVE GLOMERULONEPHRITIS
 
Renal failure
Renal failureRenal failure
Renal failure
 
Nephrotic syndrome (Primary glomerulonephrosis)
Nephrotic syndrome (Primary glomerulonephrosis)Nephrotic syndrome (Primary glomerulonephrosis)
Nephrotic syndrome (Primary glomerulonephrosis)
 
1 glomerular disease &amp; anatomy pysiology of kideny
1 glomerular disease &amp; anatomy pysiology of kideny1 glomerular disease &amp; anatomy pysiology of kideny
1 glomerular disease &amp; anatomy pysiology of kideny
 
Patho Kidney Presentation.pptx
Patho Kidney Presentation.pptxPatho Kidney Presentation.pptx
Patho Kidney Presentation.pptx
 
Nephrotic syndrome final
Nephrotic syndrome finalNephrotic syndrome final
Nephrotic syndrome final
 
Glomerular Disease sem.pptx
Glomerular Disease sem.pptxGlomerular Disease sem.pptx
Glomerular Disease sem.pptx
 
ihdsflkjashdf;hadfhadkfhasp
ihdsflkjashdf;hadfhadkfhasp ihdsflkjashdf;hadfhadkfhasp
ihdsflkjashdf;hadfhadkfhasp
 
Nephritis2008.
Nephritis2008.Nephritis2008.
Nephritis2008.
 
Renal pathology lecture 6 Rapid Progressive Glomerulonephritis & Chronic Kidn...
Renal pathology lecture 6 Rapid Progressive Glomerulonephritis & Chronic Kidn...Renal pathology lecture 6 Rapid Progressive Glomerulonephritis & Chronic Kidn...
Renal pathology lecture 6 Rapid Progressive Glomerulonephritis & Chronic Kidn...
 

More from Sufia Husain

Pathology basic introduction to pathology of common lung diseases for underg...
Pathology basic introduction to pathology of common lung diseases  for underg...Pathology basic introduction to pathology of common lung diseases  for underg...
Pathology basic introduction to pathology of common lung diseases for underg...
Sufia Husain
 
Renal pathology. Lecture 7 Introduction to Allograft Kidney Pathology. Sufia ...
Renal pathology. Lecture 7 Introduction to Allograft Kidney Pathology. Sufia ...Renal pathology. Lecture 7 Introduction to Allograft Kidney Pathology. Sufia ...
Renal pathology. Lecture 7 Introduction to Allograft Kidney Pathology. Sufia ...
Sufia Husain
 
Renal pathology lecture 4 Tumors of kidney and urinary tract. Sufia Husain 2020
Renal pathology lecture 4 Tumors of kidney and urinary tract. Sufia Husain 2020Renal pathology lecture 4 Tumors of kidney and urinary tract. Sufia Husain 2020
Renal pathology lecture 4 Tumors of kidney and urinary tract. Sufia Husain 2020
Sufia Husain
 
Renal pathology lecture 2&3. Infection of upper and lower urinary tract sufia...
Renal pathology lecture 2&3. Infection of upper and lower urinary tract sufia...Renal pathology lecture 2&3. Infection of upper and lower urinary tract sufia...
Renal pathology lecture 2&3. Infection of upper and lower urinary tract sufia...
Sufia Husain
 
Renal pathology. Lecture 1 acute kidney injury, sufia husain 2020
Renal pathology. Lecture 1  acute kidney injury, sufia husain 2020Renal pathology. Lecture 1  acute kidney injury, sufia husain 2020
Renal pathology. Lecture 1 acute kidney injury, sufia husain 2020
Sufia Husain
 
CVS Pathology 6 Vasculitis 2019 sufia husain
CVS Pathology 6 Vasculitis 2019 sufia husainCVS Pathology 6 Vasculitis 2019 sufia husain
CVS Pathology 6 Vasculitis 2019 sufia husain
Sufia Husain
 
CVS Pathology 5 Thromboembolism 2019, sufia husain
CVS Pathology 5 Thromboembolism 2019, sufia husainCVS Pathology 5 Thromboembolism 2019, sufia husain
CVS Pathology 5 Thromboembolism 2019, sufia husain
Sufia Husain
 
CVS pathology -4 Hypertension (HTN) 2019, sufia husain
CVS pathology -4 Hypertension (HTN) 2019, sufia husainCVS pathology -4 Hypertension (HTN) 2019, sufia husain
CVS pathology -4 Hypertension (HTN) 2019, sufia husain
Sufia Husain
 
HIV pathology sufia husain 2017
HIV pathology sufia husain 2017HIV pathology sufia husain 2017
HIV pathology sufia husain 2017
Sufia Husain
 
Pathology of hemodynamic disorders part 2 nov 2017 Dr. Sufia Husain
Pathology of hemodynamic disorders part 2 nov 2017 Dr. Sufia HusainPathology of hemodynamic disorders part 2 nov 2017 Dr. Sufia Husain
Pathology of hemodynamic disorders part 2 nov 2017 Dr. Sufia Husain
Sufia Husain
 
Pathology of hemodynamic disorders Part 1 nov 2017 Sufia Husain
Pathology of hemodynamic disorders Part 1 nov 2017 Sufia HusainPathology of hemodynamic disorders Part 1 nov 2017 Sufia Husain
Pathology of hemodynamic disorders Part 1 nov 2017 Sufia Husain
Sufia Husain
 
Prostate pathology, Dr. Sufia Husain, March 2018
Prostate pathology, Dr. Sufia Husain, March 2018Prostate pathology, Dr. Sufia Husain, March 2018
Prostate pathology, Dr. Sufia Husain, March 2018
Sufia Husain
 
Testicular pathology, sufia husain, 2018
Testicular pathology, sufia husain, 2018Testicular pathology, sufia husain, 2018
Testicular pathology, sufia husain, 2018
Sufia Husain
 
Breast pathology 2017 Sufia Husain
Breast pathology 2017 Sufia HusainBreast pathology 2017 Sufia Husain
Breast pathology 2017 Sufia Husain
Sufia Husain
 
Pathology of Uterine corpus. Dr. Sufia Husain, 2018
Pathology of Uterine corpus. Dr. Sufia Husain, 2018Pathology of Uterine corpus. Dr. Sufia Husain, 2018
Pathology of Uterine corpus. Dr. Sufia Husain, 2018
Sufia Husain
 
Pathology of Ectopic pregnancy, spontaneous abortion and gestational trophobl...
Pathology of Ectopic pregnancy, spontaneous abortion and gestational trophobl...Pathology of Ectopic pregnancy, spontaneous abortion and gestational trophobl...
Pathology of Ectopic pregnancy, spontaneous abortion and gestational trophobl...
Sufia Husain
 
Pathology of Polycystic ovarian disease and endometriosis 2018 sufia husain
Pathology of Polycystic ovarian disease and endometriosis 2018 sufia husainPathology of Polycystic ovarian disease and endometriosis 2018 sufia husain
Pathology of Polycystic ovarian disease and endometriosis 2018 sufia husain
Sufia Husain
 
Pathology, Ovarian Cyst and Tumors Dr. Sufia Husain 2018
Pathology, Ovarian Cyst and Tumors Dr. Sufia Husain 2018Pathology, Ovarian Cyst and Tumors Dr. Sufia Husain 2018
Pathology, Ovarian Cyst and Tumors Dr. Sufia Husain 2018
Sufia Husain
 
Pathology of uterine cervix 2018 Sufia Husain
Pathology of uterine cervix 2018 Sufia HusainPathology of uterine cervix 2018 Sufia Husain
Pathology of uterine cervix 2018 Sufia Husain
Sufia Husain
 
CVS pathology 3 - ischemic heart disease, angina and myocardial infarction 20...
CVS pathology 3 - ischemic heart disease, angina and myocardial infarction 20...CVS pathology 3 - ischemic heart disease, angina and myocardial infarction 20...
CVS pathology 3 - ischemic heart disease, angina and myocardial infarction 20...
Sufia Husain
 

More from Sufia Husain (20)

Pathology basic introduction to pathology of common lung diseases for underg...
Pathology basic introduction to pathology of common lung diseases  for underg...Pathology basic introduction to pathology of common lung diseases  for underg...
Pathology basic introduction to pathology of common lung diseases for underg...
 
Renal pathology. Lecture 7 Introduction to Allograft Kidney Pathology. Sufia ...
Renal pathology. Lecture 7 Introduction to Allograft Kidney Pathology. Sufia ...Renal pathology. Lecture 7 Introduction to Allograft Kidney Pathology. Sufia ...
Renal pathology. Lecture 7 Introduction to Allograft Kidney Pathology. Sufia ...
 
Renal pathology lecture 4 Tumors of kidney and urinary tract. Sufia Husain 2020
Renal pathology lecture 4 Tumors of kidney and urinary tract. Sufia Husain 2020Renal pathology lecture 4 Tumors of kidney and urinary tract. Sufia Husain 2020
Renal pathology lecture 4 Tumors of kidney and urinary tract. Sufia Husain 2020
 
Renal pathology lecture 2&3. Infection of upper and lower urinary tract sufia...
Renal pathology lecture 2&3. Infection of upper and lower urinary tract sufia...Renal pathology lecture 2&3. Infection of upper and lower urinary tract sufia...
Renal pathology lecture 2&3. Infection of upper and lower urinary tract sufia...
 
Renal pathology. Lecture 1 acute kidney injury, sufia husain 2020
Renal pathology. Lecture 1  acute kidney injury, sufia husain 2020Renal pathology. Lecture 1  acute kidney injury, sufia husain 2020
Renal pathology. Lecture 1 acute kidney injury, sufia husain 2020
 
CVS Pathology 6 Vasculitis 2019 sufia husain
CVS Pathology 6 Vasculitis 2019 sufia husainCVS Pathology 6 Vasculitis 2019 sufia husain
CVS Pathology 6 Vasculitis 2019 sufia husain
 
CVS Pathology 5 Thromboembolism 2019, sufia husain
CVS Pathology 5 Thromboembolism 2019, sufia husainCVS Pathology 5 Thromboembolism 2019, sufia husain
CVS Pathology 5 Thromboembolism 2019, sufia husain
 
CVS pathology -4 Hypertension (HTN) 2019, sufia husain
CVS pathology -4 Hypertension (HTN) 2019, sufia husainCVS pathology -4 Hypertension (HTN) 2019, sufia husain
CVS pathology -4 Hypertension (HTN) 2019, sufia husain
 
HIV pathology sufia husain 2017
HIV pathology sufia husain 2017HIV pathology sufia husain 2017
HIV pathology sufia husain 2017
 
Pathology of hemodynamic disorders part 2 nov 2017 Dr. Sufia Husain
Pathology of hemodynamic disorders part 2 nov 2017 Dr. Sufia HusainPathology of hemodynamic disorders part 2 nov 2017 Dr. Sufia Husain
Pathology of hemodynamic disorders part 2 nov 2017 Dr. Sufia Husain
 
Pathology of hemodynamic disorders Part 1 nov 2017 Sufia Husain
Pathology of hemodynamic disorders Part 1 nov 2017 Sufia HusainPathology of hemodynamic disorders Part 1 nov 2017 Sufia Husain
Pathology of hemodynamic disorders Part 1 nov 2017 Sufia Husain
 
Prostate pathology, Dr. Sufia Husain, March 2018
Prostate pathology, Dr. Sufia Husain, March 2018Prostate pathology, Dr. Sufia Husain, March 2018
Prostate pathology, Dr. Sufia Husain, March 2018
 
Testicular pathology, sufia husain, 2018
Testicular pathology, sufia husain, 2018Testicular pathology, sufia husain, 2018
Testicular pathology, sufia husain, 2018
 
Breast pathology 2017 Sufia Husain
Breast pathology 2017 Sufia HusainBreast pathology 2017 Sufia Husain
Breast pathology 2017 Sufia Husain
 
Pathology of Uterine corpus. Dr. Sufia Husain, 2018
Pathology of Uterine corpus. Dr. Sufia Husain, 2018Pathology of Uterine corpus. Dr. Sufia Husain, 2018
Pathology of Uterine corpus. Dr. Sufia Husain, 2018
 
Pathology of Ectopic pregnancy, spontaneous abortion and gestational trophobl...
Pathology of Ectopic pregnancy, spontaneous abortion and gestational trophobl...Pathology of Ectopic pregnancy, spontaneous abortion and gestational trophobl...
Pathology of Ectopic pregnancy, spontaneous abortion and gestational trophobl...
 
Pathology of Polycystic ovarian disease and endometriosis 2018 sufia husain
Pathology of Polycystic ovarian disease and endometriosis 2018 sufia husainPathology of Polycystic ovarian disease and endometriosis 2018 sufia husain
Pathology of Polycystic ovarian disease and endometriosis 2018 sufia husain
 
Pathology, Ovarian Cyst and Tumors Dr. Sufia Husain 2018
Pathology, Ovarian Cyst and Tumors Dr. Sufia Husain 2018Pathology, Ovarian Cyst and Tumors Dr. Sufia Husain 2018
Pathology, Ovarian Cyst and Tumors Dr. Sufia Husain 2018
 
Pathology of uterine cervix 2018 Sufia Husain
Pathology of uterine cervix 2018 Sufia HusainPathology of uterine cervix 2018 Sufia Husain
Pathology of uterine cervix 2018 Sufia Husain
 
CVS pathology 3 - ischemic heart disease, angina and myocardial infarction 20...
CVS pathology 3 - ischemic heart disease, angina and myocardial infarction 20...CVS pathology 3 - ischemic heart disease, angina and myocardial infarction 20...
CVS pathology 3 - ischemic heart disease, angina and myocardial infarction 20...
 

Recently uploaded

Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
greendigital
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
NEHA GUPTA
 
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMSAdv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
AkankshaAshtankar
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
kevinkariuki227
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Prof. Marcus Renato de Carvalho
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Oleg Kshivets
 
Light House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat EuropeLight House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat Europe
Lighthouse Retreat
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
addon Scans
 
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in DehradunDehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
chandankumarsmartiso
 
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in IndiaTop 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in India
SwastikAyurveda
 
CDSCO and Phamacovigilance {Regulatory body in India}
CDSCO and Phamacovigilance {Regulatory body in India}CDSCO and Phamacovigilance {Regulatory body in India}
CDSCO and Phamacovigilance {Regulatory body in India}
NEHA GUPTA
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
vimalpl1234
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
SumeraAhmad5
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
Anurag Sharma
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Swetaba Besh
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
Dr. Rabia Inam Gandapore
 
Vision-1.pptx, Eye structure, basics of optics
Vision-1.pptx, Eye structure, basics of opticsVision-1.pptx, Eye structure, basics of optics
Vision-1.pptx, Eye structure, basics of optics
Sai Sailesh Kumar Goothy
 

Recently uploaded (20)

Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
 
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMSAdv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
 
Light House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat EuropeLight House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat Europe
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
 
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in DehradunDehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
 
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in IndiaTop 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in India
 
CDSCO and Phamacovigilance {Regulatory body in India}
CDSCO and Phamacovigilance {Regulatory body in India}CDSCO and Phamacovigilance {Regulatory body in India}
CDSCO and Phamacovigilance {Regulatory body in India}
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
 
Vision-1.pptx, Eye structure, basics of optics
Vision-1.pptx, Eye structure, basics of opticsVision-1.pptx, Eye structure, basics of optics
Vision-1.pptx, Eye structure, basics of optics
 

Renal pathology lecture5 Nephrotic & Nephritic syndrome. Sufia Husain 2020

  • 1. April 2020 Reference: Robbins & Cotran Pathology and Rubin’s Pathology Sufia Husain Associate Professor Pathology Department College of Medicine KSU, Riyadh Renal Pathology Nephrotic Syndrome & Nephritic Syndrome
  • 2. Objectives for pathology lectures 5 & 6: Rapid Progressive Glomerulonephritis, Chronic kidney Disease, AND Nephrotic and Nephritic Syndrome: At the end of the activity (2 lectures) the students will be able to:  Recognize the five major renal glomerular syndromes.  Describe the main differential pathological diagnosis for each syndrome.  Perform a clinico-pathological correlation.  Describe the patterns of injury of each syndrome. Key Outlines:  The nephrotic syndrome: (Minimal change, FSGS, membranous, diabetes).  The nephritic syndrome: (Acute post streptococcal Glomerulonephritis GN, Lupus nephritis).  Asymptomatic Hematuria: IgA Nephropathy.  Rapidly progressive GN: (Crescentic GN)  The Chronic Renal Failure.
  • 3. Outline for lecture 5  Introduction, kidney biopsy  Location of electron dense immune deposits  Pathogenesis of glomerular disease  Common markers of renal diseases  Clinical manifestation of kidney disease  Nephrotic Syndrome  Minimal change disease  Focal segmental glomerulosclerosis  Membranous GN  Diabetes mellitus  Nephritic Syndrome  Acute post-streptococcal GN  Introduction to lupus nephritis  Hematuria  IgA Nephropathy
  • 4.
  • 8. The tissue obtained is used to make slides for 1. Light microscopy (LM) to study renal histology. 2. Immunofluorescence (IF) study is to detect  the presence of immunoglobulins (IgA, IgG, IgM) and complements (C3 and C1q) in the glomeruli (in the mesangium or in the glomerular capillary loop wall. 3. Electron microscopy (EM) (ultrastructural) study is to detect the presence or absence of  effacement of the epithelial cell (podocytes)foot processes.  electron dense immune complex deposits  And if deposits are present then to identify the location of the deposits in the glomeruli (mesangial/paramesangial, subepithelial, subendothelial). Kidney biopsy
  • 9. LOCATIONS OF ELECTRON DENSE IMMUNE DEPOSITS
  • 10. Deposits (depicted in black)Normal glomerular capillary loop Common locations of electron dense immune deposits. Note: the locations are different in different diseases. Image from IM Bajema et al.: Revision of lupus nephritis classification. Kidney International · February 2018 DOI: 10.1016/j.kint.2017.11.023
  • 12. Pathogenesis of glomerular injury Glomerulonephritis (GN) is frequently caused by immunologic mechanisms both antibody-mediated (mainly) and cell-mediated types of immunity play roles in the production of glomerular inflammation. 1. Antibody-mediated immune GN: there are 3 major mechanisms of antibody-mediated inflammation. They are: a) In situ immune complex formation: certain circulating antibodies react with certain antigens that are already present in glomeruli  formation deposition of these immune complexes in the glomeruli. These deposits attract leukocytes and activate complement glomerular injury.
  • 13. Pathogenesis of glomerular injury contd.. b) Antigen-antibody reaction take place in circulation and these preformed circulating immune complexes are deposited in the glomeruli  deposits trigger glomerular injury (by attracting inflammatory cells and activate complements). (the antigen can be a bacteria, virus etc.)
  • 14. Pathogenesis of glomerular injury contd.. c) Antineutrophil cytoplasmic autoantibodies (ANCAs): they cause a severe type of GN in which the patients have circulating autoantibodies against antigens present in neutrophil cytoplasm. This interaction leads to activation and adhesion of the neutrophils to endothelial cells lining the capillaries especially the glomerular capillaries. The neutrophils release injurious products that promote endothelial injury, vascular inflammation (vasculitis) and GN. All 3 initiate of glomerular inflammatory injury by attraction and activation of leukocytes. 2. Cell mediated immune GN: sensitized T cells also cause glomerular injury. https://unckidneycenter.org/files/2017/10/anca-vasculitis-vessel-wall.png
  • 15. COMMON MARKERS OF RENAL DISEASES
  • 16. In blood  Serum creatinine and BUN In urine analysis  Proteinuria: presence of abnormal quantities of protein in the urine  Hematuria: presence of rbcs in urine (smoky brown urine). It is a result of glomerular injury and rupture of the glomerular capillaries with resultant bleeding into the Bowman’s/ urinary space.  Casts: these rbcs mix with proteinaceous material in the tubules and forms rbc casts (which are found in the urine). Common markers of renal diseases https://unckidneycenter.org/files
  • 17. CLINICAL MANIFESTATION OF KIDNEY DISEASE
  • 18. Clinical manifestation of kidney disease  Nephritic syndrome Results from glomerular injury  acute onset of hematuria (rbcs in urine), mild to moderate proteinuria, azotemia, edema & hypertension.  Nephrotic syndrome heavy proteinuria (excretion of more than 3.5 g of protein/day in urine), hypoalbuminemia, severe edema, hyperlipidemia, and lipiduria.  Asymptomatic hematuria &/or non-nephrotic proteinuria a sign of mild glomerular abnormalities e.g. IgA nephropathy.  Rapidly progressive glomerulonephritis Results from severe glomerular injury  loss of renal function within days or weeks  hematuria, dysmorphic rbcs, rbc casts in urine, mild to moderate proteinuria.  Acute kidney injury oliguria or anuria with recent onset of azotemia; can result from glomerular injury (e.g. crescentic glomerulonephritis), interstitial injury, vascular injury (e.g. TMA) or acute tubular injury/necrosis.  Chronic kidney disease any chronic renal diseases that progresses to end stage kidney requiring dialysis and transplantation.  Urinary tract infection affect the kidney (pyelonephritis) or the bladder (cystitis)  bacteriuria and pyuria (bacteria and leukocytes in urine).  Nephrolithiasis (renal stones) renal colic, hematuria (without rbc casts).
  • 19.  DIFFUSE: majority of the glomeruli are involved  FOCAL: some of the glomeruli are involved  SEGMENTAL: only part of a glomerular tuft is involved  GLOBAL: involving the total glomerular tuft Terminology
  • 21. Nephrotic syndrome is a group of clinical features that include the following: 1. Massive proteinuria: is the loss in the urine of >3.5 g of protein/day. This is due abnormal permeability of the glomerular capillary wall. 2. Hypoproteinemia or hypoalbuminemia: plasma albumin levels <3g/dL (this due to the loss of protein in the urine) 3. Odema: Hypoproteinemia causes reduced plasma colloid osmotic pressure, salt and water retention and odema. 4. Hyperlipidemia and lipiduria: hypoalbuminemia causes compensatory increase in lipoprotein secretion by the liver leading to hyperlipidemia. At the same time there is increased loss of lipid in the urine, lipiduria (due to abnormal permeability of the GBM). Note: in the beginning there is little or no azotemia, hematuria, or hypertension (not part of definition of nephrotic syndrome). Nephrotic syndrome
  • 22. PRIMARY CAUSES  Minimal change disease  Membranous GN  Focal segmental glomerulosclerosis (FSGS)  Membranoproliferative GN (can also present as nephritic syndrome)  Others SECONDARY CAUSES  Diabetes mellitus (most common systemic causes)  Amyloidosis  Systemic lupus erythematosus (it can also present as nephritic syndrome)  Drugs (gold, penicillamine, "street heroin")  Others NOTE: In children the most common cause of nephrotic syndrome is minimal-change disease. In adults the most common primary glomerular diseases that causes nephrotic syndrome are membranous glomerulopathy in Caucasians and Asians, and FSGS is the most common etiology in American blacks. Causes of nephrotic syndrome
  • 24. Minimal change disease (MCD) is also known as lipoid nephrosis. It causes nephrotic syndrome. Pathogenesis: unknown  usually idiopathic. It is characterized by effacement of the foot processes of the visceral epithelial cells (podocytes). Light microscopy: • Glomeruli  look normal. • The proximal convoluted tubular cells are heavily laden with protein droplets and lipids. • There is no tubular atrophy or interstitial fibrosis. Immunofluorescence microscopy: • Is negative for immunoglobulins and complement. Minimal change disease /glomerulopathy
  • 25. MCD: Electron microscopy: • MCD is characterized by diffuse fusion or effacement of the epithelial cell (podocyte) foot processes. • This effacement is due to the retraction of the foot processes as a result of extensive cell swelling. NOTE: effacement occurs in virtually all cases of nephrotic proteinuria; it is not specific for minimal-change glomerulopathy.
  • 26. MCD: clinical features, treatment and prognosis C/F include:  Nephrotic syndrome Treatment and prognosis:  Over 90% of children and few adults have complete remission with corticosteroid therapy.  Prognosis: good, especially in children.  Some patients become steroid dependent i.e. they relapse each time corticosteroid treatment is stopped.  Less than 5% develop chronic renal failure
  • 27. FOCAL AND SEGMENTAL GLOMERULOSCLEROSIS (FSGS)
  • 28. FOCAL AND SEGMENTAL GLOMERULOSCLEROSIS (FSGS) LM:  Occurs in older children and adults.  Glomeruli at the corticomedullary junction are commonly affected.  Only some of the glomeruli are involved (i.e. focal).  There is focal and segmental sclerosis of the glomeruli (i.e. some glomeruli show sclerosis in a segment of the glomerular tuft).  Adhesions and hyalinosis +/- IF: Usually negative. Sometimes IgM is positive. EM: There is patchy/focal effacement of podocyte foot processes.
  • 30.  A frequent cause of the nephrotic syndrome in adults (commonly 30-50 years).  The proteinuria does not usually respond to corticosteroid therapy  Is an immune complex disease. The antigen-antibody immune complexes are formed either in-situ in the glomeruli or are pre-formed in circulation and then deposited in the glomeruli.  It is characterized by deposition of electron dense immune complexes in the subepithelial area in the glomeruli (between the podocytes and the GBM).  It is a slowly progressive disease. If not treated some cases  progress to fibrosis of the kidneys (glomerular sclerosis, atrophy of tubules and interstitial fibrosis) and end stage disease/ renal failure.  10% to 30% have a more benign course with good prognosis. Membranous glomerulopathy/ nephropathy/ GN
  • 31. Membranous glomerulopathy can be: Primary/idiopathic membranous GN (80% of cases): in primary MN there are autoantibodies against phospholipase A2 receptor 1 (PLA2R1) antigen. Secondary membranous GN: causes include autoimmune disease (SLE), infectious disease (hepatitis B virus infection), therapeutic agents (penicillamine), neoplasms (lung cancer). Patient should be investigated for secondary causes. Membranous glomerulopathy/ nephropathy/ GN
  • 32. Membranous glomerulopathy/ nephropathy/ GN Light microscopy:  The capillary walls of the glomeruli are diffusely thickened (due to the subepithelial deposits seen on EM).  The deposits are separated from each other by protrusions of GBM matrix called spikes (bottom picture).  As the disease progresses there is glomerular sclerosis and interstitial fibrosis.
  • 33. Membranous GN IF: granular positivity for immunoglobulin IgG and complement C3 along the GBM. EM: the immune complex appear in capillary walls as electron-dense deposits in the subepithelial space. There is diffuse effacement of epithelial cell foot processes also.
  • 35. DIABETIC NEPHROPATHY (DM) Long standing poorly controlled DM  leads to kidney disease. Is a common cause of secondary nephrotic syndrome. LM: shows 2 types of lesions: 1. Diffuse glomerulosclerosis: all the glomeruli show increase in mesangial matrix ending in sclerosis (top photo). 2. Nodular glomerulosclerosis (Kimmelstiel Wilson nodules): there are nodules in the mesangium. These nodules are spherical and eosinophilic, with a central acellular area. It is pathogonomic of diabetic nephropathy (bottom photo). Both show diffuse thickening of the glomerular basement membrane If not treated can progress to  end staged kidney/ renal failure. IF: negative. EM: there is diffuse increase in the thickness of the glomerular basement membrane.
  • 37. Nephritic syndrome is a clinical complex characterized by acute onset of:  Hematuria (smoky brown urine). The hematuria is a result of glomerular injury and inflammatory rupture of the glomerular capillaries with resultant bleeding into the Bowman’s space. The rbcs pass into the tubules and mix with proteinaceous material in the tubules and forms rbc casts (which are passed in the urine). The hemodynamic changes caused by the rupture lead to a reduction in the glomerular filteration rate (GFR).  Oliguria: is a result of the reduced GFR.  Azotemia: increased blood urea nitrogen and creatinine. It is also a result of reduced GRF.  Hypertension: it is a result of the fluid retention and renin release from the ischemic kidneys. NOTE: There may be mild proteinuria and edema. The example of nephritic syndrome include:  Post-infectious glomerulonephritis: it is the most classical example.  Lupus nephritis: can also present as nephrotic syndrome Nephritic syndrome
  • 39. Post-infectious glomerulonephritis (PIGN) It is a type of acute diffuse proliferative GN. It is caused by deposition of immune complexes in glomeruli. The most common cause of post-infectious glomerulonephritis is infection with group A, beta-hemolytic streptococci and is therefore also called post- streptococcal glomerulonephritis . Other infections include pneumococcal and staphylococcal infections and viral diseases (mumps, measles, chickenpox etc.). Usually there is a latent period between the exposure and the occurrence of glomerulonephritis Classically PIGN develops in children 1 to 4 weeks after streptococcal infection of the pharynx (pharyngitis) or tonsils (tonsillitis) or the skin (impetigo or infected insect bite). This disease was more common in the past (because now we have antibiotics), but it is still one of the common childhood renal diseases.
  • 40. Post-infectious GN: pathogenesis  The immune complexes are deposited in the glomeruli in the subepithelial area and are composed of IgG and C3. The deposits initiate inflammation by  activating complements: this way the complements get used up leading to development of hypocomplementemia (serum C3 levels are low during the acute phase of disease).  And activating various other inflammatory mediators All these inflammatory mediators:  attracts and activate neutrophils and monocytes  stimulates proliferation of mesangial and endothelial cell proliferation. These effects result in marked glomerular hypercellularity  resulting in diffuse proliferative glomerulonephritis.
  • 41. Post-infectious GN: Light microscopy There is diffuse enlargement and hypercellularity of glomeruli due to proliferation of endothelial cells and mesangial cells and infiltration of neutrophils and monocytes. Crescents maybe present. Glomerular necrosis maybe present. All histologic changes resolve completely in most patients after several months
  • 42. https://www.stepwards.com/wp- content/uploads/2016/01/j6npaxvA2gcDQTLLEm7mdQ_m.png IF: coarse granular (lumpy bumpy) IgG and C3 are positive along the capillary walls. EM: characteristic subepithelial electron dense immune deposits. They look like dome shaped humps (called subepithelial humps). The deposits clear up and disappear in a few months. Post-infectious GN https://basicmedicalkey.com/wp-content/uploads/2016/12/image08134.jpeg
  • 43. Post-infectious GN: clinical features The onset of kidney disease is sudden. Present as nephritic syndrome (oliguria, hematuria, hypertension and azotemia). Serum C3 levels are low during the acute phase. Diagnosis depends on serologic evidence of a rise in antibody titers to streptococcal products e.g. ASO titre is positive. This disease resolves in over 90% of patients. Rarely patients (usually adults) develop progressive renal failure. Grossly there is multiple punctate hemorrhagic spots on the kidney surface.
  • 45. LUPUS NEPHROPATHY/ NEPHRITIS (LN) Patients with the autoimmune disease called systemic lupus erythematosus (SLE) tend to have renal involvement and it is known as lupus nephritis (LN). It can present as nephrotic or nephritic syndrome. LN is an immune complex mediated disease in which there is the deposition of antigen antibody complexes in the glomeruli. The deposits trigger an inflammatory response which in turn triggers the proliferation of the epithelial, endothelial and mesangial cells of the glomeruli. It can even lead to glomerular necrosis. LN can be active or chronic or a combination of both. The LN lesions have been classified into 6 classes by the International Society of Nephrology/Renal Pathology Society (ISN/RPS). This classification helps give information regarding the activity, chronicity and the prognosis of the disease.
  • 47.  IgA nephropathy (IgAN) is one of the most common type of primary glomerulonephritis that presents as hematuria  IgAN is characterized by the deposition of IgA immunoglobulin in the mesangium/ paramesangium of glomeruli.  It usually present as hematuria only and sometimes as nephritic syndrome.  When it occurs in combination with vasculitis (leukocytoclastic vasculitis) and multiorgan involvement then is referred to as Henoch-Schonlein purpura. Hematuria
  • 48. IgA Nephropathy/Bergers disease LM: is very variable (may or may not show  mesangial hypercellularity, endocapillary hypercellularity, glomerular sclerosis, tubulo-interstitial scarring). IF: dominant IgA stain positivity in the mesangium. EM: immune complex deposits positive in the mesangium and paramesangial area. https://webpath.med.utah.edu/jpeg2/RENAL096.jpg https://abdominalkey.com/wp-content/uploads/2016/06/C12-FF21-3.gif
  • 49. END